Home › Trials › NCT05909033
Clinical trial No longer in our active list Observational Ages 6 Months to 6

Identifying early predictors of liver survival in biliary atresia patients after surgery

Official title: Early Predictors for the Short Term Native Liver Survival in Patients With Biliary Atresia After Kasai Procedure

Run by Nanjing Children's Hospital · NCT05909033 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is trying to find out which early signs can help doctors predict how well the liver will survive after surgery in kids with biliary atresia.

More Biliary Atresia trials

Quick facts

Study typeObservational
Ages6 Months to 6 Years
SexAll
Enrollment150 (estimated)
SponsorNanjing Children's Hospital
Academic / other
Locations1 site (Nanjing)
Trial IDNCT05909033 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are infants diagnosed with biliary atresia who have undergone the Kasai procedure and have completed at least six months of follow-up.

Probably not a fit

Patients who have not undergone the Kasai procedure or those with severe complications leading to death may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate and identify preoperative and early postoperative factors that influence native liver survival (NLS) in patients with biliary atresia who have undergone the Kasai procedure. Biliary atresia is a serious condition that often leads to the need for liver transplants, and understanding early predictors of NLS could help in making timely decisions regarding transplant needs. The study will analyze various factors, including age at surgery and biochemical markers, to establish their correlation with liver survival outcomes. By focusing on early predictors, the research seeks to improve patient counseling and management strategies.

Why it matters

Potential benefit: If successful, this study could lead to improved early identification of biliary atresia patients at risk for liver failure, allowing for timely interventions.

How similar studies have gone: While many studies have explored factors affecting liver survival in biliary atresia, this specific focus on early predictors post-Kasai procedure is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

Biliary Atresia(BA) patients performed with Kasai Procedure patients completed the follow-up\>6 months

Exclusion Criteria:

BA patients without KP patients lost of follow-up BA patients with other severe complications lead to death

Where it's running

  • Children's Hospital of Nanjing Medical University
    Nanjing, China     Recruiting

Study contacts

  • Principal investigator: Weibing Tang, Dr — Children's Hospital of Nanjing Medical University
  • Study coordinator: Changgui Lu, Dr
  • Email: luchanggui1984@163.com
  • Phone: 13770848448

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Biliary Atresia 23Nanjing Children's Hospital 4
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.